Companies that handle massive amounts of user data are often the least careful with it. Last year, the National Public Data breach exposed 2.7 billion records. The company’s entire business model was ...
Genmab Relies on IDBS’ ActivityBase XE for Analyzing Results from Its Discovery Activities Therapeutic monoclonal antibodies are the fastest growing segment within the pharmaceutical market. Among ...
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible individuals prefer a blood test for colorectal cancer ...
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. As part of its bid to transform the future of cancer screening and seize control of ...
Please provide your email address to receive an email when new articles are posted on . Over 80% of people at high risk for lung cancer were unaware of screening or had not discussed it with a doctor.
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it has provided genomic newborn screenings (gNBS) for ...
A data breach at DISA Global Solutions, Inc., a third-party employment screening services provider, affected more than 3.3 million people, the company said. The company, which provides drug and ...
Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...
DISA Global Solutions, a U.S.-based provider of employee screening services, has said it suffered a data breach that affects more than 3.3 million people. DISA, which provides services like drug and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback